SNIBE(SZ:300832) Xin Lang Cai Jing·2026-01-09 02:50Core Viewpoint - The stock price of New Industry has shown a positive trend, with a year-to-date increase of 10.83%, indicating strong market interest and potential growth in the biomedical sector [2]. Group 1: Stock Performance - As of January 9, New Industry's stock price increased by 2.01%, reaching 62.34 CNY per share, with a trading volume of 66.98 million CNY and a turnover rate of 0.16% [1]. - The stock has experienced a 10.83% increase in price this year, with a 10.83% rise over the last five trading days and a 7.30% increase over the last 20 days, while it has slightly decreased by 0.45% over the last 60 days [2]. Group 2: Company Overview - New Industry, established on December 15, 1995, and listed on May 12, 2020, is based in Shenzhen, Guangdong Province, specializing in the research, development, production, and sales of fully automated chemiluminescence immunoassay instruments and related reagents [2]. - The company's revenue composition is as follows: reagents account for 69.62%, instruments for 30.21%, and other sources for 0.16% [2]. Group 3: Financial Performance - For the period from January to September 2025, New Industry reported a revenue of 3.428 billion CNY, reflecting a year-on-year growth of 0.39%, while the net profit attributable to shareholders decreased by 12.92% to 1.205 billion CNY [2]. - Since its A-share listing, New Industry has distributed a total of 3.86 billion CNY in dividends, with 2.357 billion CNY distributed over the past three years [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders for New Industry was 13,100, a decrease of 15.87% from the previous period, with an average of 51,997 circulating shares per shareholder, an increase of 18.87% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 26.4824 million shares, an increase of 4.2383 million shares from the previous period, while other notable shareholders include Huabao Zhongzheng Medical ETF and Yifangda Blue Chip Selected Mixed Fund [3].